FDx Advisors Inc. purchased a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 7,922 shares of the medical instruments supplier’s stock, valued at approximately $335,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in MMSI. LS Investment Advisors LLC raised its position in Merit Medical Systems by 8.1% during the 2nd quarter. LS Investment Advisors LLC now owns 3,694 shares of the medical instruments supplier’s stock worth $141,000 after purchasing an additional 277 shares during the last quarter. Louisiana State Employees Retirement System raised its position in Merit Medical Systems by 1.5% during the 2nd quarter. Louisiana State Employees Retirement System now owns 20,300 shares of the medical instruments supplier’s stock worth $774,000 after purchasing an additional 300 shares during the last quarter. Aperio Group LLC raised its position in Merit Medical Systems by 3.9% during the 2nd quarter. Aperio Group LLC now owns 10,467 shares of the medical instruments supplier’s stock worth $399,000 after purchasing an additional 391 shares during the last quarter. Suntrust Banks Inc. raised its position in Merit Medical Systems by 5.6% during the 2nd quarter. Suntrust Banks Inc. now owns 7,847 shares of the medical instruments supplier’s stock worth $299,000 after purchasing an additional 414 shares during the last quarter. Finally, Strs Ohio raised its position in Merit Medical Systems by 1.7% during the 2nd quarter. Strs Ohio now owns 29,300 shares of the medical instruments supplier’s stock worth $1,117,000 after purchasing an additional 500 shares during the last quarter. Institutional investors own 89.47% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “FDx Advisors Inc. Purchases New Position in Merit Medical Systems, Inc. (MMSI)” was published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.watchlistnews.com/fdx-advisors-inc-purchases-new-position-in-merit-medical-systems-inc-mmsi/1719456.html.

In other Merit Medical Systems news, Director Kent W. Stanger sold 670 shares of Merit Medical Systems stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $42.06, for a total transaction of $28,180.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 5.00% of the stock is currently owned by insiders.

Several research analysts have recently weighed in on MMSI shares. ValuEngine raised Merit Medical Systems from a “hold” rating to a “buy” rating in a research report on Tuesday. SunTrust Banks, Inc. set a $47.00 price objective on Merit Medical Systems and gave the stock a “buy” rating in a research report on Thursday, November 16th. Zacks Investment Research raised Merit Medical Systems from a “hold” rating to a “buy” rating and set a $43.00 price objective for the company in a research report on Saturday, October 28th. Canaccord Genuity lifted their price objective on Merit Medical Systems from $45.00 to $47.50 and gave the stock a “buy” rating in a research report on Thursday, October 26th. Finally, Raymond James Financial, Inc. reissued an “outperform” rating and issued a $44.00 price objective on shares of Merit Medical Systems in a research report on Monday, August 28th. One analyst has rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $42.02.

Shares of Merit Medical Systems, Inc. (MMSI) opened at $43.55 on Wednesday. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.78 and a quick ratio of 1.43. The company has a market capitalization of $2,103.33, a PE ratio of 32.99, a PEG ratio of 2.84 and a beta of 1.20. Merit Medical Systems, Inc. has a 12 month low of $23.25 and a 12 month high of $45.50.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.30 by $0.02. The company had revenue of $179.30 million during the quarter, compared to the consensus estimate of $181.28 million. Merit Medical Systems had a return on equity of 9.86% and a net margin of 4.06%. The firm’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period last year, the business posted $0.26 EPS. analysts anticipate that Merit Medical Systems, Inc. will post 1.27 earnings per share for the current year.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.